Northwest Biotherapeutics (NWBO) claims that the market makers deliberately engaged in repeated manipulative spoofing of its stock from December 5, 2017 – August 1, 2022, causing NWBO to issue more than 49 million shares at artificially depressed prices in violation of Section 10(b), Rule 10b-5 and Section 9(a)(2) of the Securities Exchange Act of 1934. NWBO also claims that their alleged actions also constitute as fraud under New York state common law.
Let's hope their suit is successful. This is illegal but neither the DOJ nor the SEC seem interested in going after the Rat Bastards.